Regentatlantic Capital LLC Maravai Lifesciences Holdings, Inc. Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
A detailed history of Regentatlantic Capital LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 8,897 shares of MRVI stock, worth $20,463. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,897
Previous 10,246
13.17%
Holding current value
$20,463
Previous $291,000
21.99%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MRVI
# of Institutions
204Shares Held
138MCall Options Held
271KPut Options Held
37.6K-
Gtcr LLC20.2MShares$46.3 Million10.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$27.2 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY11.6MShares$26.7 Million6.99% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$22.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$19.2 Million2.55% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $303M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...